Ironwood Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	28.55	0.88	-1,002	175.07	528.45	106.18
Depreciation & Amortization	1.91	2.01	1.58	1.42	1.52	2.36
Loss (Gain) From Sale of Assets	0.09	0.08	-	0	0.09	0.47
Asset Writedown & Restructuring Costs	-	-	1,095	-	-	1.2
Stock-Based Compensation	17.99	29.85	32.01	27.05	22.28	31.18
Other Operating Activities	85.41	69.99	45.36	67.41	-308.18	28.39
Change in Accounts Receivable	-44.16	47.24	0.92	7.99	7.71	4.09
Change in Inventory	-	-	-	-	-	0.65
Change in Accounts Payable	0.77	-20.21	12.38	-8.12	-2.64	-7.52
Change in Unearned Revenue	-	-	-	-	-	-0.88
Change in Other Net Operating Assets	-22.88	-26.29	-2.03	2.94	12.66	2.72
Operating Cash Flow	67.68	103.55	183.43	273.76	261.9	168.84
Operating Cash Flow Growth	-45.49%	-43.55%	-33.00%	4.53%	55.12%	1474.23%
Capital Expenditures	-0.04	-0.14	-0.27	-0.14	-0.27	-1.84
Cash Acquisitions	-	-	-1,026	-	-	-
Investing Cash Flow	-0.04	-0.14	-1,026	-0.14	-0.27	-1.84
Long-Term Debt Issued	-	150	400	-	-	-
Long-Term Debt Repaid	-	-265	-100	-120.7	-	-
Net Debt Issued (Repaid)	-15	-115	300	-120.7	-	-
Issuance of Common Stock	0.3	11.01	6.36	9.54	19.58	18.55
Repurchase of Common Stock	-	-0.74	-	-126.39	-24.13	-
Other Financing Activities	-0.09	-2.25	-29.2	-	-	-
Financing Cash Flow	-14.79	-106.97	277.16	-237.55	-4.55	18.55
Foreign Exchange Rate Adjustments	-0.66	-0.03	-0.05	-	-	-
Net Cash Flow	52.2	-3.6	-565.78	36.07	257.08	185.54
Free Cash Flow	67.65	103.41	183.15	273.63	261.63	166.99
Free Cash Flow Growth	-45.36%	-43.54%	-33.06%	4.58%	56.67%	4622.68%
Free Cash Flow Margin	19.96%	29.43%	41.37%	66.64%	63.23%	42.87%
Free Cash Flow Per Share	0.39	0.65	1.18	1.47	1.59	1.04
Cash Interest Paid	32.56	32.56	13.55	5.75	7.22	7.22
Cash Income Tax Paid	8.41	8.41	9.95	4.62	3.45	1.85
Levered Free Cash Flow	39.12	80.31	204.13	161.46	170.05	98.04
Unlevered Free Cash Flow	60.23	101.11	217.5	166.21	189.52	116.46
Change in Working Capital	-66.27	0.74	11.28	2.82	17.73	-0.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.